State govt.to extend financial protection to Guillain-Barré Syndrome (GBS)  patients

State govt.to extend financial protection to Guillain-Barré Syndrome (GBS)  patients

Why in news :

• The State government will extend financial protection to patients suffering from Guillain-Barré Syndrome (GBS), a rare neurological condition

Key Highlights

• Launched by: The Karnataka State Government, announced by Health Minister Dinesh Gundu Rao and implemented via a circular from the Suvarna Arogya Suraksha Trust (SAST).
• Core Purpose: To extend financial protection to patients suffering from Guillain-Barré Syndrome (GBS), a rare neurological condition, by covering the cost of the critical and expensive Intravenous Immunoglobulin (IVIG) therapy.
• Scheme Integration: The treatment is now brought under the Ayushman Bharat–Arogya Karnataka (AB-PMJAY–CM’s ArK)
• Coverage & Financials:
  • The revised package covers up to ₹2 lakh per patient for IVIG therapy.
  • The drug price is fixed at ₹2,000 per gram.
  • Dosage coverage is calculated based on patient weight (2 grams per kg body weight, up to a maximum of 20 grams per cycle).
  • Two specific procedure codes have been created for billing and auditing.

Additional information

Guillain-Barré Syndrome (GBS)

• About :GBS is a rare autoimmune disorder where the immune system attacks the peripheral nerves, causing muscle weakness and potentially paralysis.
• Occurrence: It affects about 1–2 per 100,000 people annually, appearing more frequently in adults and males.
• Triggers: It usually follows a viral or bacterial infection, such as Campylobacter jejuni, influenza, Zika virus, or (rarely) vaccinations.
• Symptoms:
  • Early: Tingling and weakness starting in the legs and spreading upward, pins-and-needles sensation, and back pain.
  • Severe: Paralysis, difficulty breathing, loss of speech, and vision problems.
  • Complications: Can disrupt heart rate and blood pressure, or lead to respiratory failure.
• Treatment: While there is no definitive cure, treatments include:
  • IVIG Therapy: Infusing healthy antibodies to block the immune attack.
  • Plasma Exchange: Removing harmful antibodies from the blood.
  • Supportive Care: Use of ventilators (if breathing fails) and physical therapy for rehabilitation.